0001022079-18-000133.txt : 20180529
0001022079-18-000133.hdr.sgml : 20180529
20180529163726
ACCESSION NUMBER: 0001022079-18-000133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180525
FILED AS OF DATE: 20180529
DATE AS OF CHANGE: 20180529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUINAN MARK
CENTRAL INDEX KEY: 0001505998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 18865001
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_152762623294219.xml
FORM 4
X0306
4
2018-05-25
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001505998
GUINAN MARK
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
Executive Vice President & CFO
Common Stock
2018-05-25
4
M
0
61533
58.365
A
119733
D
Common Stock
2018-05-25
4
S
0
36573
105.418
D
83160
D
Common Stock
2018-05-25
4
S
0
24960
106.139
D
58200
D
Stock Options (Right to Buy)
58.365
2018-05-25
4
M
0
61533
58.365
D
2023-08-19
Common Stock
61533.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018.
This transaction was executed in multiple trades at prices ranging from $105.00 to $105.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $106.00 to $106.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three equal annual installments beginning with the first on August 19, 2014, the second on August 19, 2015 and the final on August 19, 2016.
/s/ William J. O'Shaughnessy, Jr., attorney-in-fact for Mark J. Guinan
2018-05-29